GOLD I期慢阻肺患者一氧化碳弥散量降低的临床与预后影响
本研究纳入360例GOLD肺功能I期COPD患者并随访109±50个月,发现Dlco<60%预计值与全因死亡率升高相关(23% vs 9%,P=.01),且该阈值与更差的临床表型独立相关。多因素Cox回归证实Dlco<60%是全因死亡的独立预测因子(HR 3.37,95%CI 1.35-8.39;P=.009)。
要点
- GOLD I期COPD患者中Dlco<60%预计值与全因死亡风险增加相关。
- Dlco<60%者即使FEV1%和Charlson评分相同,临床表型也更差。
- Dlco<60%是全因死亡的独立预测因子,HR为3.37。
核心结论
- 在GOLD I期COPD患者中,Dlco<60%预计值与死亡风险增加和更差的临床表型相关。
研究设计与样本
- 纳入360例GOLD肺功能I期COPD患者,随访109±50个月,记录人口学、肺功能、运动能力、BODE指数和急性加重史。
主要发现
- Dlco<60%预计值者全因死亡率为23%,Dlco≥60%者为9%(P=.01)。
- 在相同FEV1%预计值和Charlson评分下,Dlco<60%者BMI更低、呼吸困难更重、IC/TLC比值更低、6MWD更短、BODE指数更高。
- 多因素Cox回归调整年龄、性别、包年史、吸烟状态和BMI后,Dlco<60%仍与全因死亡相关(HR 3.37,95%CI 1.35-8.39;P=.009)。
关键数值与推荐
- Dlco<60%预计值为本研究中识别全因死亡风险增加的阈值。
临床怎么用
- 在GOLD I期COPD评估中可考虑检测Dlco,Dlco<60%预计值提示死亡风险增加和临床表型更差。
局限性
- 该关联的原因及可否治疗尚待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Global Initiative for Obstructive Lung Disease (GOLD) does not promote diffusing capacity for carbon monoxide (Dlco) values in the evaluation of COPD. In GOLD spirometric stage I COPD patients, the clinical and prognostic impact of a low Dlco has not been explored. RESEARCH QUESTION: Could a Dlco threshold help define an increased risk of death and a different clinical presentation in these patients? STUDY DESIGN AND METHODS: GOLD stage I COPD patients (n = 360) were enrolled and followed over 109 ± 50 months. Age, sex, pack-years' history, BMI, dyspnea, lung function measurements, exercise capacity, BODE index, and history of exacerbations were recorded. A cutoff value for Dlco was identified for all-cause mortality and the clinical and physiological characteristics of patients above and below the threshold compared. Cox regression analysis explored the predictive power of that cutoff value for all-cause mortality. RESULTS: A Dlco cutoff value of <60% predicted was associated with all-cause mortality (Dlco ≥ 60%: 9% vs Dlco < 60%: 23%, P = .01). At a same FEV1% predicted and Charlson score, patients with Dlco < 60% had lower BMI, more dyspnea, lower inspiratory capacity (IC)/total lung capacity (TLC) ratio, lower 6-min walk distance (6MWD), and higher BODE. Cox multiple regression analysis confirmed that after adjusting for age, sex, pack-years history, smoking status, and BMI, a Dlco < 60% is associated with all-cause mortality (hazard ratio [HR], 95% CI = 3.37, 1.35-8.39; P = .009) INTERPRETATION: In GOLD I COPD patients, a Dlco < 60% predicted is associated with increased risk of death and worse clinical presentation. What the cause(s) of this association are and whether they can be treated need to be determined.
引用
- de-Torres JP, O'Donnell DE, Marín JM, et al. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD. Chest. 2021. PMID: 33901498. doi:10.1016/j.chest.2021.04.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。